Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Pfizer (NYSE:PFE) Stock Price Down 0.1% - Should You Sell?
Pfizer (NYSE:PFE) Trading Down 0.5% - What's Next?
Advisors Management Group Inc. ADV Has $5.10 Million Position in Pfizer Inc. (NYSE:PFE)
Pfizer (NYSE:PFE) Shares Down 0.1% - What's Next?
Bruce Murray's Top Picks: Air Canada, Uber and META - BNN Bloomberg
Humira Holds Firm at 72% Market Share--AbbVie Fends Off Biosimilar Surge
Beech Hill Advisors Inc. Sells 26,454 Shares of Pfizer Inc. (NYSE:PFE)
Roble Belko & Company Inc Has $154,000 Stock Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Holdings Lowered by Smith Anglin Financial LLC
Burney Co. Acquires 104,112 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by Assenagon Asset Management S.A.
Pines Wealth Management LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Pfizer (NYSE:PFE) Stock Price Down 0.6% - What's Next?
Pfizer (NYSE:PFE) Shares Down 0.3% - Here's What Happened
Pfizer Inc. (NYSE:PFE) Shares Sold by Brendel Financial Advisors LLC
Pfizer (NYSE:PFE) Shares Down 0.3% - Should You Sell?
Rosenberg Matthew Hamilton Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)
Global Financial Private Client LLC Cuts Stock Position in Pfizer Inc. (NYSE:PFE)
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale (3)
Pfizer Inc. (NYSE:PFE) Shares Sold by Meyer Handelman Co.
Radnor Capital Management LLC Sells 17,005 Shares of Pfizer Inc. (NYSE:PFE)
Rockland Trust Co. Has $11.40 Million Stake in Pfizer Inc. (NYSE:PFE)
Wynn Capital LLC Has $585,000 Stock Position in Pfizer Inc. (NYSE:PFE)
Why Pfizer sold its $3 billion stake in Haleon By Invezz
Pfizer Sells GBP 2.50 Bln Of Shares In Haleon | Markets Insider
Pfizer To Sell €2.96bn Stake In Sensodyne Maker Haleon
Pfizer Sells Stake in Haleon for $3.05 Billion
Pfizer to further reduce stake in Haleon through share sale By Proactive Investors
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion | Morningstar
HEALTHCARE: Pfizer (PFE: A2 / A): Selling more of Haleon stake
Bernstein Reaffirms Their Hold Rating on Pfizer (PFE)
CR Pharmaceutical, NAMI join forces to fight Alzheimer's with Pfizer cancer drug | South China Morning Post
Health Care Slides After Lilly Warning - Health Care Roundup | Morningstar
Sasanlimab Plus BCG Could Alter Treatment Paradigm in BCG-Naive, High-Risk NMIBC
Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner - The Economic Times
Wallace Advisory Group LLC Buys 616 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer sells £2.5bn of Haleon as blocks market heats up
Pfizer (NYSE:PFE) Stock Price Down 0.5% - Here's Why
Pfizer offers to sell 700 mln more shares of Haleon
Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports By Investing.com
Pfizer Offers to Sell 700 Million More Shares of Haleon
Pfizer to sell 7.7% Haleon stake through bookbuilding By Investing.com
Oak Asset Management LLC Sells 5,528 Shares of Pfizer Inc. (NYSE:PFE)
Horizon Bancorp Inc. IN Sells 14,336 Shares of Pfizer Inc. (NYSE:PFE)
BCS Wealth Management Takes Position in Pfizer Inc. (NYSE:PFE)
Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner By Reuters
First National Bank Sioux Falls Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Position Increased by Claro Advisors LLC
Pfizer Inc. (NYSE:PFE) Shares Bought by Kwmg LLC
Pallas Capital Advisors LLC Boosts Stake in Pfizer Inc. (NYSE:PFE)
First National Bank Sioux Falls Cuts Position in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by Founders Capital Management
J&J CEO Lauds Caplyta Buy, Pfizer CEO Disses RFK Jr.'s Anti-Vax Stance 01/14/2025
J&J CEO Lauds Caplyta, Pfizer's Disses RFK Jr. Anti-Vax Stance 01/14/2025
Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know - January 14, 2025 - Zacks.com
J&J CEO Lauds Caplyta Buy, Pfizer CEO Unloads On RFK Jr 01/14/2025
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight
Pallas Capital Advisors LLC Purchases 125,351 Shares of Pfizer Inc. (NYSE:PFE)
Viral Claims About Vaccine Side Effects Are Misleading
Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline
Pfizer (NYSE:PFE) Stock Price Down 0.6% - Time to Sell?
Pfizer Inc. (NYSE:PFE) Shares Acquired by Adams Asset Advisors LLC
Capital Investment Advisors LLC Reduces Holdings in Pfizer Inc. (NYSE:PFE)
Vaccination campaigns against Covid-19 and RSV in Uruguay
Capital Investment Advisors LLC Trims Stock Position in Pfizer Inc. (NYSE:PFE)
Is Pfizer Inc. (PFE) the Most Reliable Dividend Stock to Buy According to Hedge Funds?
City State Bank Has $599,000 Stake in Pfizer Inc. (NYSE:PFE)
Czech National Bank Acquires 74,350 Shares of Pfizer Inc. (NYSE:PFE)
Bernstein selects LLY stock as top pick in biopharma sector By Investing.com
Lovebombing Trump: How US multinationals in Ireland will deal with the incoming president
Sickle Cell Disease Pipeline Status 2024: Clinical Trials, MOA, ROA by DelveInsight | Sanofi, Novartis AG, Bluebird Biotech, Pfizer Inc., Aruvant Sciences Inc., Glycomimetics, Global Blood Therapeutic | ABNewswire
Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study - January 13, 2025 - Zacks.com
Pfizer To Present At J.P. Morgan Healthcare Conference; Webcast At 12:45 PM ET
Pfizer Inc. (NYSE:PFE) Shares Sold by ORG Wealth Partners LLC
Jacobs & Co. CA Lowers Position in Pfizer Inc. (NYSE:PFE)
Highline Wealth Partners LLC Decreases Position in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by LVM Capital Management Ltd. MI
Pfizer Must Face Lawsuit Over Diversity, Court Rules | Newsmax.com
Pfizer (NYSE:PFE) Trading Up 0.3% - Here's Why
What to Expect From Pfizer's Next Quarterly Earnings Report
Pfizer, Sandoz Settle Patent Suit on Mektovi Cancer Drug Copies
Hilltop National Bank Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)
DEI Challenge to Pfizer Fellowship Revived in 2d Cir. Rehearing
Standing Spat: Split 2nd Circuit Lets Challenge to Pfizer Diversity Program Proceed
Donald Trump: After Jeff Bezos, Zuckerberg, now CEO of this multinational retail corp cozies up to Trump at Mar-a-Lago - The Economic Times
Dow, Verizon, Pfizer: Blue-Chip Stocks With High Yields
Arvinas outlines 2025 clinical trial plans for breast cancer drug By Investing.com
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update | The Manila Times
Pfizer Inc (PFE) Announces Promising Phase 3 Trial Results for Sasanlimab in Bladder Cancer ...
Pfizer must face lawsuit over diversity fellowship program, US court rules By Reuters
Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns | Investing.com
Pfizer's bladder cancer therapy meets main goal in late-stage study By Reuters
Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded Deal - January 10, 2025 - Zacks.com
Latest news
Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK
Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration